Related Experiment Video
Updated: Jan 1, 2026

Author Spotlight: Decoding RNA Methylation's Role in Pancreatic Cancer - A Single-Base Resolution Study
Published on: July 7, 2023
m6A RNA modification modulates gene expression and cancer-related pathways in clear cell renal cell carcinoma
Yimeng Chen1, Cuixing Zhou1, Yangyang Sun1
1Department of Urology, The Third Affiliated Hospital of Soochow University, Changzhou 213003, Jiangsu, China.
Abstract:
Aim: To systematically profile the global m6A modification pattern in clear cell renal cell carcinoma (ccRCC). Methods: m6A modification patterns in ccRCC and normal tissues were described via m6A sequencing and RNA sequencing, followed by bioinformatics analysis. m6A-related RNAs were immunoprecipitated and validated by quantitative real-time PCR (qPCR). Results: In total, 6919 new m6A peaks appeared with the disappearance of 5020 peaks in ccRCC samples. The unique m6A-related genes in ccRCC were associated with cancer-related pathways. We identified differentially expressed mRNA transcripts with hyper-methylated or hypo-methylated m6A peaks in ccRCC. Conclusion: This study presented the first m6A transcriptome-wide map of human ccRCC, which may shed lights on possible mechanisms of m6A-mediated gene expression regulation.
Insights
This study maps N6-methyladenosine (m6A) modifications in clear cell renal cell carcinoma (ccRCC), revealing significant changes in m6A patterns and identifying novel m6A-related genes involved in cancer pathways.
Area of Science:
- Molecular Biology
- Genomics
- Cancer Research
Background:
- N6-methyladenosine (m6A) is the most prevalent internal mRNA modification.
- Dysregulation of m6A modification is implicated in various cancers, including renal cell carcinoma.
- Understanding m6A patterns in clear cell renal cell carcinoma (ccRCC) is crucial for elucidating its oncogenic mechanisms.
Purpose of the Study:
- To systematically profile the global m6A modification landscape in ccRCC.
- To identify differentially methylated m6A peaks and associated genes in ccRCC.
- To explore the role of m6A-mediated gene regulation in ccRCC development.
Main Methods:
- m6A-seq and RNA-seq were performed on ccRCC and normal tissues.
- Bioinformatics analysis was used to identify m6A peaks and differentially expressed genes.
- Quantitative real-time PCR (qPCR) was employed for validation of m6A-related RNAs.
Main Results:
- A total of 6919 new m6A peaks emerged, and 5020 peaks disappeared in ccRCC samples.
- Unique m6A-related genes in ccRCC were found to be associated with cancer-related pathways.
- Differentially expressed mRNA transcripts with hyper- or hypo-methylated m6A peaks were identified in ccRCC.
Conclusions:
- This study provides the first comprehensive transcriptome-wide m6A map for human ccRCC.
- The findings offer insights into potential mechanisms of m6A-driven gene expression regulation in ccRCC.
- This m6A map may serve as a foundation for future research into ccRCC pathogenesis and therapeutic strategies.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MicroRNAs
MicroRNAs
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Regulation of Expression at Multiple Steps

